Medical Device News Magazine

ACC Urges Lawmakers to Support Bill to Avoid Medicare Cuts Threatening Patient Access to Care

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The American College of Cardiology is urging members of Congress to co-sponsor and pass the Preserving Seniors’ Access to Physicians Act of 2023 (H.R. 6683), which would eliminate the impending 3.37% cut to the Medicare Physician Fee Schedules set to take effect on Jan. 1, 2024.

“We have once again arrived at American clinicians’ annual holiday tradition: urging Congress to not allow cuts to Medicare services that exacerbate financial uncertainty for practices, further threaten patient access to care, and disproportionately impact America’s rural and senior populations,” said American College of Cardiology President B. Hadley Wilson, MD, FACC. “For decades we have spent December looking for a quick fix to a problem that requires significant reforms. We must seek and establish sustainable payment practices that allow clinicians to continue providing access to high-quality care. While addressing this upcoming cut is critical, it is a short-term adjustment that will not create a long-term solution. It is necessary to protect patients now while we work together on lasting reform.”

A full fix to the 3.37% cut is necessary to combat the lack of inflationary update despite clinicians and practices facing significant inflationary cost pressure. Physicians are the only providers that do not receive an automatic inflationary update within Medicare. Medicare physician payments have dropped by 26% in the last 20 years, while practice expenses have risen by 47% over the same period. Congress must act now to avert this crisis to maintain stable, consistent access to care for some of America’s most vulnerable patients.

The ACC is leading the charge to transform cardiovascular care delivery. Tasked with advocating for cardiovascular patients and providing a professional home for the entire cardiovascular team, the ACC is committed to developing and advancing solutions that will optimize the delivery of cardiovascular care, increase access to care and improve patient outcomes and health. However, significant reforms are required within the current Medicare system to achieve the ACC’s vision. Learn more about the ACC’s Vision for Optimal Cardiovascular Care at

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”